<p>Selected adverse reactions (all grades) that were reported in &lt; 10% of patients treated with Axitinib&nbsp;included dizziness (9%), upper abdominal pain (8%),&nbsp;myalgia&nbsp;(7%), dehydration (6%),&nbsp;epistaxis&nbsp;(6%),&nbsp;anemia&nbsp;(4%),&nbsp;hemorrhoids&nbsp;(4%),&nbsp;hematuria&nbsp;(3%),&nbsp;tinnitus&nbsp;(3%), lipase increased (3%), glossodynia (3%),&nbsp;pulmonary embolism&nbsp;(2%), rectal hemorrhage (2%),&nbsp;hemoptysis&nbsp;(2%),&nbsp;deep vein thrombosis&nbsp;(1%), retinal-veinocclusion/thrombosis&nbsp;(1%),&nbsp;polycythemia&nbsp;(1%), and&nbsp;transient ischemic attack&nbsp;(1%).</p>